Target- |
MechanismPhotosensitizers |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismReactive oxygen species stimulants [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Ernco 200 LTD
0 Patents (Medical) associated with Ernco 200 LTD
100 Deals associated with Ernco 200 LTD
100 Translational Medicine associated with Ernco 200 LTD